A phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic Pancreatic Cancer

Flak, Rasmus Virenfeldt (Projektkoordinator)
Ladekarl, Morten (PI (principal investigator))
Poulsen, Laurids Østergaard (Projektkoordinator)
Thorlacius-Ussing, Ole (Andet)
Stender, Mogens Tornby (Andet)
Detlefsen, Sönke (CoI (co-investigator))
Agger, Ralf (CoI (co-investigator))
Kofod-Olsen, Emil (CoI (co-investigator))
Wanders, Alkwin (CoI (co-investigator))

Projektdetaljer

Beskrivelse

An investigator initiated clinical trial of combined immunotherapy (PD1-inhibitor) and irreversible electroporation in patients with metastatic pancreatic cancer.
The aim is to examine the efficacy and safety of the combined treatment.

Kort titel	Electroporation Potentiated Immunotherapy in Cancer – 1.st study
Akronym	EPIC-1
Status	Igangværende
Effektiv start/slut dato	01/01/2021 → 31/12/2025